|
1
|
Sattar N, Forrest E and Preiss D:
Non-alcoholic fatty liver disease. BMJ. 349:g45962014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Browning JD, Szczepaniak LS, Dobbins R,
Nuremberg P, Horton JD, Cohen JC, Grundy SM and Hobbs HH:
Prevalence of hepatic steatosis in an urban population in the
United States: impact of ethnicity. Hepatology. 40:1387–1395. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong VW, Chu WC, Wong GL, Chan RS, Chim
AM, Ong A, Yeung DK, Yiu KK, Chu SH, Woo J, et al: Prevalence of
nonalcoholic fatty liver disease and advanced fibrosis in Hong Kong
Chinese: a population study using proton-magnetic resonance
spectroscopy and transient elastography. Gut. 61:409–415. 2012.
View Article : Google Scholar
|
|
4
|
Henao-Mejia J, Elinav E, Jin C, Hao L,
Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ,
et al: Inflammasome-mediated dysbiosis regulates progression of
NAFLD and obesity. Nature. 482:179–185. 2012.PubMed/NCBI
|
|
5
|
Lavallard VJ and Gual P: Autophagy and
non-alcoholic fatty liver disease. Biomed Res Int. 2014:1201792014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hassanian M, Al-Mulhim A, Al-Sabhan A,
Al-Amro S, Bamehriz F, Abdo A and Al Khalidi H: The effect of
bariatric surgeries on nonalcoholic fatty liver disease. Saudi J
Gastroenterol. 20:270–278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu Y, Ma Z, Zhang Z, Xiong X, Wang X,
Zhang H, Shi G, Xia X, Ning G and Li X: Yin Yang 1 promotes hepatic
steatosis through repression of farnesoid X receptor in obese mice.
Gut. 63:170–178. 2014. View Article : Google Scholar
|
|
8
|
Dhibi M, Brahmi F, Mnari A, Houas Z,
Chargui I, Bchir L, Gazzah N, Alsaif MA and Hammami M: The intake
of high-fat diet with different trans fatty acid levels
differentially induces oxidative stress and non alcoholic fatty
liver disease (NAFLD) in rats. Nutr Metab (Lond). 8:652011.
View Article : Google Scholar
|
|
9
|
Wei J, Sun X, Chen Y, Li Y, Song L, Zhou
Z, Xu B, Lin Y and Xu S: Perinatal exposure to bisphenol A
exacerbates nonalcoholic steatohepatitis-like phenotype in male rat
offspring fed on a high-fat diet. J Endocrinol. 222:313–325. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu J, Zhang H, Zheng H and Jiang Y:
Hepatic inflammation scores correlate with common carotid
intima-media thickness in rats with NAFLD induced by a high-fat
diet. BMC Vet Res. 10:1622014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dyson JK, Anstee QM and McPherson S:
Non-alcoholic fatty liver disease: a practical approach to
treatment. Frontline Gastroenterol. 5:277–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meyerrose TE, De Ugarte DA, Hofling AA,
Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands
MS, Hedrick MA and Nolta JA: In vivo distribution of human
adipose-derived mesenchymal stem cells in novel xenotransplantation
models. Stem Cells. 25:220–227. 2007. View Article : Google Scholar
|
|
13
|
Philippe B, Luc S, Valérie PB, Jérôme R,
Alessandra BR and Louis C: Culture and use of mesenchymal stromal
cells in phase I and II clinical trials. Stem Cells Int.
2010:5035932010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu K, Liu R, Cao G, Sun H and Wangxand Wu
S: Adipose-derived stromal cell autologous transplantation
ameliorates pulmonary arterial hypertension induced by shunt flow
in rat models. Stem Cells Dev. 20:1001–1010. 2011. View Article : Google Scholar
|
|
15
|
Eirin A, Zhu XY, Krier JD, Tang H, Jordan
KL, Grande JP, Lerman A, Textor SC and Lerman LO: Adipose
tissue-derived mesenchymal stem cells improve revascularization
outcomes to restore renal function in swine atherosclerotic renal
artery stenosis. Stem Cells. 30:1030–1041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okura H, Saga A, Fumimoto Y, Soeda M,
Moriyama M, Moriyama H, Nagai K, Lee CM, Yamashita S, Ichinose A,
et al: Transplantation of human adipose tissue-derived multilineage
progenitor cells reduces serum cholesterol in hyperlipidemic
Watanabe rabbits. Tissue Eng Part C Methods. 17:145–154. 2011.
View Article : Google Scholar :
|
|
17
|
Ji AT, Chang YC, Fu YJ, Lee OK and Ho JH:
Niche-dependent regulations of metabolic balance in high-fat
diet-induced diabetic mice by mesenchymal stromal cells. Diabetes.
64:926–936. 2015. View Article : Google Scholar
|
|
18
|
Zhang Y, Chen XM and Sun DL: Effects of
coencapsulation of hepatocytes with adipose-derived stem cells in
the treatment of rats with acute-on-chronic liver failure. Int J
Artif Organs. 37:133–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saito Y, Shimada M, Utsunomiya T, Ikemoto
T, Yamada S, Morine Y, Imura S, Mori H, Sugimoto K, Iwahashi S and
Asanoma M: The protective effect of adipose-derived stem cells
against liver injury by trophic molecules. J Surg Res. 180:162–168.
2013. View Article : Google Scholar
|
|
20
|
Harn HJ, Lin SZ, Hung SH, Subeq YM, Li YS,
Syu WS, Ding DC, Lee RP, Hsieh DK, Lin PC and Chiou TW:
Adipose-derived stem cells can abrogate chemical-induced liver
fibrosis and facilitate recovery of liver function. Cell
Transplant. 21:2753–2764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Banas A, Teratani T, Yamamoto Y, Tokuhara
M, Takeshita F, Quinn G, Okochi H and Ochiya T: Adipose
tissue-derived mesenchymal stem cells as a source of human
hepatocytes. Hepatology. 46:219–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi H, Haraguchi N, Nishikawa S,
Miyazaki S, Suzuki Y, Mizushima T, Nishimura J, Takemasa I,
Yamamoto H, Mimori K, et al: Biological and clinical availability
of adipose-derived stem cells for pelvic dead space repair. Stem
Cells Transl Med. 1:803–810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ibrahim MA, Kelleni M and Geddawy A:
Nonalcoholic fatty liver disease: current and potential therapies.
Life Sci. 92:114–118. 2013. View Article : Google Scholar
|
|
25
|
Shaker M, Tabbaa A, Albeldawi M and
Alkhouri N: Liver transplantation for nonalcoholic fatty liver
disease: new challenges and new opportunities. World J
Gastroenterol. 20:5320–5330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mollica MP, Lionetti L, Moreno M, Lombardi
A, De Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A and
Goglia F: 3,5-diiodo-l-thyronine, by modulating mitochondrial
functions, reverses hepatic fat accumulation in rats fed a high-fat
diet. J Hepatol. 51:363–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y,
Zhang L and Wang Y: High-fat emulsion-induced rat model of
nonalcoholic steatohepatitis. Life Sci. 79:1100–1107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takaki A, Kawai D and Yamamoto K:
Molecular mechanisms and new treatment strategies for non-alcoholic
steatohepatitis (NASH). Int J Mol Sci. 15:7352–7379. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thoma C, Day CP and Trenell MI: Lifestyle
interventions for the treatment of non-alcoholic fatty liver
disease in adults: a systematic review. J Hepatol. 56:255–266.
2012. View Article : Google Scholar
|
|
30
|
Ezquer M, Ezquer F, Ricca M, Allers C and
Conget P: Intravenous administration of multipotent stromal cells
prevents the onset of non-alcoholic steatohepatitis in obese mice
with metabolic syndrome. J Hepatol. 55:1112–1120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Winkler S, Borkham-Kamphorst E, Stock P,
Brückner S, Dollinger M, Weiskirchen R and Christ B: Human
mesenchymal stem cells towards non-alcoholic steatohepatitis in an
immunodeficient mouse model. Exp Cell Res. 326:230–239. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gutiérrez-Fernández M, Rodríguez-Frutos B,
Ramos-Cejudo J, Teresa Vallejo-Cremades M, Fuentes B, Cerdán S and
Díez-Tejedor E: Effects of intravenous administration of allogenic
bone marrow- and adipose tissue-derived mesenchymal stem cells on
functional recovery and brain repair markers in experimental
ischemic stroke. Stem Cell Res Ther. 4:112013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie X, Wang Y, Zhao C, Guo S, Liu S, Jia
W, Tuan RS and Zhang C: Comparative evaluation of MSCs from bone
marrow and adipose tissue seeded in PRP-derived scaffold for
cartilage regeneration. Biomaterials. 33:7008–7018. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Valina C, Pinkernell K, Song YH, Bai X,
Sadat S, Campeau RJ, Le Jemtel TH and Alt E: Intracoronary
administration of autologous adipose tissue-derived stem cells
improves left ventricular function, perfusion, and remodelling
after acute myocardial infarction. Eur Heart J. 28:2667–2677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Niemeyer P, Kornacker M, Mehlhorn A,
Seckinger A, Vohrer J, Schmal H, Kasten P, Eckstein V, Südkamp NP
and Krause U: Comparison of immunological properties of bone marrow
stromal cells and adipose tissue-derived stem cells before and
after osteogenic differentiation in vitro. Tissue Eng. 13:111–121.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun CK, Chang CL, Lin YC, Kao YH, Chang
LT, Yen CH, Shao PL, Chen CH, Leu S and Yip HK: Systemic
administration of autologous adipose-derived mesenchymal stem cells
alleviates hepatic ischemia-reperfusion injury in rats. Crit Care
Med. 40:1279–1290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Seki T, Yokoyama Y, Nagasaki H, Kokuryo T
and Nagino M: Adipose tissue-derived mesenchymal stem cell
transplantation promotes hepatic regeneration after hepatic
ischemia-reperfusion and subsequent hepatectomy in rats. J Surg
Res. 178:63–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
